Baxter International (HAM:BTL) Valuation Rank


HAM:BTL Baxter International Inc HAM:BTL
59 GF Score
Price €19.31
GF Value €30.15
! 6 Warning Signs
View Full Analysis

What is Baxter International Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Baxter International Valuation Rank Related Terms

HAM:BTL
59GF Score
Baxter International Inc HAM:BTL
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Baxter International (HAM:BTL) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of €19.31 is trading 36% below its estimated GF Value™ of €30.15.

Key valuation signals for HAM:BTL:

  • Valuation Rank:
  • GF Value™: €30.15 vs. price of €19.31 (36% below fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the HAM:BTL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
59GF Score

Get the complete analysis for HAM:BTL

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.31
Price
€30.15
GF Value